Showing results (1701-1710 of 2,364) with videos related to
Sort By:
Pageof 237
Journal of the American College of Cardiology|August 18, 2022
Association of Medication Adherence With Health Outcomes in the ISCHEMIA TrialR Angel Garcia, John A Spertus, Mary C Benton, et al.Frontiers in Cardiovascular Medicine|January 3, 2022
Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial InfarctionXiaolin Zhang, Minghui Cheng, Naijing Gao, et al.Journal of the American College of Cardiology|May 18, 2004
Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarctionAmir Halkin, Cindy L Grines, David A Cox, et al.Vaccine|May 11, 2020
A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapySuresh Pallikkuth, Hector Bolivar, Mary A Fletcher, et al.Circulation|December 23, 2009
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trialStuart J Pocock, Roxana Mehran, Tim C Clayton, et al.Journal of the American College of Cardiology|May 23, 2009
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialRamin Ebrahimi, Cornelius Dyke, Roxana Mehran, et al.JACC. Cardiovascular Interventions|May 26, 2009
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialA Michael Lincoff, Steven R Steinhubl, Steven V Manoukian, et al.Circulation|January 28, 2009
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trialGregg W Stone, Mark Midei, William Newman, et al.Circulation|June 3, 2011
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trialTullio Palmerini, Roxana Mehran, George Dangas, et al.Journal of the American College of Cardiology|January 5, 2008
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trialsStuart J Pocock, Alexandra J Lansky, Roxana Mehran, et al.Pageof 237